A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

A new drug to potentially treat depression and neurodegenerative diseases, such as dementia or Parkinson’s, is being ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

New research suggests that the risk for developing dementia is significantly higher than previously estimated, and the burden ...

This class of drugs was associated with a 20% lower risk of dementia compared to another diabetes medication known as dipeptidyl peptidase-4 (DPP4) inhibitors. SGLT2 inhibitors help lower blood ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

The findings highlight the need for public-health strategies aimed at mitigating dementia risk and promoting healthy aging across diverse populations, researchers said. “I think ...

A recent study by researchers at the University of California, San Francisco, found that people who frequently use sleep medications may face a higher risk of developing dementia. This risk ...

An estimated 50m people live with dementia globally, more than two-thirds of them in low- and middle-income countries. In 2024, the first drugs that can change the course of Alzheimer’s disease ...

Axovant has axed development of its key dementia drug intepirdine after results suggested it actually worsened symptoms compared with placebo. The news sent the neurology-focused Swiss biotech’s ...

While overall, combinations of cardiovascular drugs decreased dementia risk, only antihypertensives were able to do so alone with antiplatelets even increasing risk. Long-term combinatorial use of ...